Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
468.85Prev. Close
467.15Volume
1,004Total traded value
0.05 CrUpper Circuit
560.55Lower Circuit
373.75Fundamentals
| Market Cap | ₹3,328Cr |
| ROE | 5.98% |
| P/E Ratio(TTM) | 37.64 |
| EPS(TTM) | 12.56 |
| P/B Ratio | 1.37 |
| Dividend Yield | 0.00% |
| Industry P/E | 33.48 |
| Book Value | 345.83 |
| Debt to Equity | 0.21 |
| Face Value | 2 |
Understand Fundamentals
Financials
About Unichem Laboratories
Unichem Laboratories is a global pharmaceutical company that manufactures Active Pharmaceutical Ingredients (APIs) and a wide range of finished drug formulations for international markets. It is driven by a commitment to quality and excellence, aiming to surpass stringent global manufacturing standards required for business in regulated markets. Demonstrating significant operational growth, its formulation output increased by 52%, reaching 15.17 billion tablets and capsules in the financial year 2025.;
| Parent Organisation | Unichem Laboratories |
| Managing Director | Mr. Pabitrakumar Bhattacharyya |
| NSE Symbol | UNICHEMLAB |
Shareholding Pattern
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Top Mutual Funds Invested(2)
| FUND NAME | AUM(%) |
|---|---|
| DSP Healthcare Fund Direct Growth | 1.28% |
| HDFC Small Cap Fund Direct Growth | 0.67% |
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.61 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 32.73 | ||
| Cohance Lifesciences | NA (0.00%) | 68.91 | ||
| Wockhardt | NA (0.00%) | -392.85 |